Key highlights from Consultation on the CHVI Research and Development Alliance (September -October 2010)

The Canadian HIV Vaccine Initiative (CHVI) participating departments and agencies (Canadian International Development Agency, Public Health Agency of Canada, Industry Canada, Canadian Institutes of Health Research, and Health Canada) and the Bill & Melinda Gates Foundation undertook a consultation on the CHVI Research and Development Alliance.

The objective of the consultation was to seek input on how best to implement the CHVI Research and Development Alliance, the Alliance Coordinating Office as well as to determine how the Alliance can best contribute to achieving the 2010 Scientific Strategic Plan of the Global HIV Vaccine Enterprise.

Input was sought from Canadian and international stakeholders, through a three pronged approach:

• Web-based consultation;
• A face-to-face meeting which took place on September 23, 2010 in Ottawa (targeted to a small group of key stakeholders such as Canadian HIV community groups, researchers, research institutions engaged in HIV vaccine activities, infectious disease organizations and the private sector; and
• One-on-one interviews (with selected key international stakeholders).

The summary report of the consultation highlights key areas of input received through the web-based consultation, the face-to-face meeting and the one-on-one interviews.  

A brief summary has been prepared to demonstrate how the key input received through the consultation process has informed the final Invitation to Submit Applications.